SCHEMBL5481635

SCHEMBL5481635

COc1cccc(C2(C(=O)Nc3ccc(N4CCOCC4)cc3)CCN(c3ncccn3)CC2)c1

nearest known ligand 0.51

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MAPT P10636 13/20 0.51
KDM4E B2RXH2 2/20 0.51
POLB P06746 1/20 0.51
LMNA P02545 2/20 0.48
NPC1 O15118 2/20 0.47
TSHR P16473 2/20 0.47
MEN1 O00255 2/20 0.47
KMT2A Q03164 2/20 0.47
HPGD P15428 1/20 0.47
TP53 P04637 1/20 0.47
CSF1R P07333 1/20 0.46
ALDH1A1 P00352 3/20 0.46
QSOX1 O00391 1/20 0.46
PKM P14618 1/20 0.46
RAB9A P51151 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
MAPK1 P28482 1/20 0.45
HCRTR1 O43613 1/20 0.45
NPSR1 Q6W5P4 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5482986 0.82 KDM4E (0.48) MAPTKDM4ELMNANPC1TSHR
Hydrochloric Acid SCHEMBL5492877 0.82 GRIN2B (0.51) MAPTKDM4ELMNANPC1TSHR
SCHEMBL5487731 0.82 ALDH1A1 (0.53) MAPTKDM4ENPC1TSHRMEN1
SCHEMBL4873649 0.80 ALDH1A1 (0.56) MAPTKDM4ENPC1TSHRMEN1
Hydrochloric Acid SCHEMBL5488843 0.80 ALDH1A1 (0.49) MAPTKDM4ENPC1TSHRMEN1
Hydrochloric Acid SCHEMBL5489145 0.80 MEN1 (0.51) MAPTKDM4ELMNANPC1TSHR
SCHEMBL5475033 0.79 MAPT (0.58) MAPTKDM4ELMNANPC1TSHR
SCHEMBL4877181 0.78 ALDH1A1 (0.56) MAPTKDM4ELMNANPC1TSHR
SCHEMBL4876692 0.78 ALDH1A1 (0.49) MAPTKDM4ENPC1TSHRMEN1
SCHEMBL4868393 0.78 ALDH1A1 (0.48) MAPTKDM4ENPC1TSHRMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070078120-A1 Novel piperidine derivative DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2007-04-05 US disclosed
EP-1679069-A1 NOVEL PIPERIDINE DERIVATIVE Dainippon Sumitomo Pharma Co., Ltd. (JP) 2006-07-12 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070078120-A1 Novel piperidine derivative LDLR, PRMT5, MSR1 MAPT 4793/4885KDM4E 728/4885POLB 3309/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.